Evolva presents its sustainable, next-generation ingredients at the FlavourTalk conference

Evolva will present its sustainable, next-generation ingredients at FlavourTalk in Amsterdam. FlavourTalk is a key conference in the area of flavour technology and formulation. Contact us if you will be attending and would like to schedule a meeting with either Benoit Palms or Michael Malone to learn more about Evolva and the unique value proposition of our brewed specialty ingredients valencene and nootkatone.Evolva Vice President Business Development Benoit Palms

Evolva Vice President Business Development Benoit Palms will present “21st Century Brewing” on Thursday, February 23rd at 10:15 at the New Technologies and Legislation Session chaired by Lindsey Bagley.

You are invited to visit our valencene and nootkatone website ahead of the event for more information about our company, technology and products. Also, check out Evolva’s resveratrol, Veri-teTM which is a functional ingredient important for healthy ageing through bone health, cardiovascular health, blood glucose control, healthy cognitive function, skin youthfulness and oral health. (see www.veriteresveratrol.com). For more information and a free 10-gram resveratrol sample go to Evolva’s WebShop. Our WebShop is designed to service small and medium sized business-to-business customers.


– ends –

Download press release in English

About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video.
Contact Details

Michael Malone, Commercial F&F
+ 41 79 412 9401
Benoit Palms, VP Business Development
+ 41 79 432 27 42

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.